| Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 JD Steinmetz, KM Seeher, N Schiess, E Nichols, B Cao, C Servili, ... The Lancet Neurology 23 (4), 344-381, 2024 | 1532 | 2024 |
| Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial PB Gilbert, DC Montefiori, AB McDermott, Y Fong, D Benkeser, W Deng, ... Science 375 (6576), 43-50, 2022 | 1240 | 2022 |
| Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine RA Seder, LJ Chang, ME Enama, KL Zephir, UN Sarwar, IJ Gordon, ... Science 341 (6152), 1359-1365, 2013 | 1034 | 2013 |
| Live attenuated malaria vaccine designed to protect through hepatic CD8+ T cell immunity JE Epstein, K Tewari, KE Lyke, BKL Sim, PF Billingsley, MB Laurens, ... Science 334 (6055), 475-480, 2011 | 712 | 2011 |
| RTS, S/AS01 vaccine (Mosquirix™): an overview MB Laurens Human vaccines & immunotherapeutics 16 (3), 480-489, 2020 | 647 | 2020 |
| A field trial to assess a blood-stage malaria vaccine MA Thera, OK Doumbo, D Coulibaly, MB Laurens, A Ouattara, AK Kone, ... New England Journal of Medicine 365 (11), 1004-1013, 2011 | 489 | 2011 |
| Protection against malaria at 1 year and immune correlates following PfSPZ vaccination AS Ishizuka, KE Lyke, A DeZure, AA Berry, TL Richie, FH Mendoza, ... Nature medicine 22 (6), 614-623, 2016 | 453 | 2016 |
| Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria SL Hoffman, PF Billingsley, E James, A Richman, M Loyevsky, T Li, ... Hum Vaccin 6 (1), 97-106, 2010 | 423 | 2010 |
| Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection KE Lyke, AS Ishizuka, AA Berry, S Chakravarty, A DeZure, ME Enama, ... Proceedings of the National Academy of Sciences 114 (10), 2711-2716, 2017 | 303 | 2017 |
| Safety and efficacy of a typhoid conjugate vaccine in Malawian children PD Patel, P Patel, Y Liang, JE Meiring, T Misiri, F Mwakiseghile, JK Tracy, ... New England Journal of Medicine 385 (12), 1104-1115, 2021 | 158 | 2021 |
| A three-component biomarker panel for prediction of dengue hemorrhagic fever AR Brasier, H Ju, J Garcia, HM Spratt, SS Victor, BM Forshey, ES Halsey, ... The American journal of tropical medicine and hygiene 86 (2), 341, 2012 | 139 | 2012 |
| Vaccines against malaria A Ouattara, MB Laurens Clinical Infectious Diseases 60 (6), 930-936, 2015 | 127 | 2015 |
| Molecular basis of allele-specific efficacy of a blood-stage malaria vaccine: vaccine development implications A Ouattara, S Takala-Harrison, MA Thera, D Coulibaly, A Niangaly, ... The Journal of infectious diseases 207 (3), 511-519, 2013 | 112 | 2013 |
| Plasmodium vivax infections over 3 years in Duffy blood group negative Malians in Bandiagara, Mali A Niangaly, K Gunalan, A Ouattara, D Coulibaly, JM Sa, M Adams, ... The American journal of tropical medicine and hygiene 97 (3), 744, 2017 | 104 | 2017 |
| A randomized trial of artesunate mefloquine versus artemether lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Senegalese children B Faye, JL Ndiaye, R Tine, K Sylla, A Gueye, AC Lô, O Gaye The American journal of tropical medicine and hygiene 82 (1), 140, 2010 | 95* | 2010 |
| Safety and immunogenicity of an AMA1 malaria vaccine in Malian children: results of a phase 1 randomized controlled trial MA Thera, OK Doumbo, D Coulibaly, MB Laurens, AK Kone, AB Guindo, ... PloS one 5 (2), e9041, 2010 | 94 | 2010 |
| The promise of a malaria vaccine—are we closer? MB Laurens Annual review of microbiology 72 (1), 273-292, 2018 | 88 | 2018 |
| Stable malaria incidence despite scaling up control strategies in a malaria vaccine-testing site in Mali D Coulibaly, MA Travassos, AK Kone, Y Tolo, MB Laurens, K Traore, ... Malaria journal 13 (1), 374, 2014 | 84 | 2014 |
| Spatio-temporal analysis of malaria within a transmission season in Bandiagara, Mali D Coulibaly, S Rebaudet, M Travassos, Y Tolo, M Laurens, AK Kone, ... Malaria journal 12 (1), 82, 2013 | 84 | 2013 |
| Ad35. CS. 01-RTS, S/AS01 heterologous prime boost vaccine efficacy against sporozoite challenge in healthy malaria-naive adults CF Ockenhouse, J Regules, D Tosh, J Cowden, A Kathcart, J Cummings, ... PLoS One 10 (7), e0131571, 2015 | 81 | 2015 |
